Form 4: HealthEquity Director Stuart B. Parker Reports Acquisition of Common Stock

Director Stuart B. Parker reports acquisition of 771 shares of HealthEquity, Inc. common stock through vesting of restricted stock units.

Summary

• On February 3, 2025, Stuart B. Parker, a director of HealthEquity, Inc., acquired 771 shares of common stock.
• The acquisition was due to the vesting of restricted stock units, with a price of $0 per share.
• Following the transaction, Parker directly owns 19,832 shares of HealthEquity, Inc.
• The vested shares will be delivered on February 1, 2028, or upon a change of control, termination of service, or death of the reporting person prior to that date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to executive compensation. The acquisition of shares by a director is generally viewed as a positive sign, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The remaining restricted stock units will vest on May 1, 2025, August 1, 2025 and November 1, 2025.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Comparison to Industry Standards

• Stock grants and vesting schedules are standard components of executive compensation packages in the healthcare and technology industries.
• Companies like Teladoc Health and Cerner (now Oracle Health) also utilize stock-based compensation to align executive interests with shareholder value.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates confidence from a company director.

Key Dates

Keywords

HealthEquity, Director, Stuart B. Parker, Common Stock, Restricted Stock Units, Vesting, Form 4, SEC